Screening for malignant neoplasm of vagina (Z12. 72) Screening for HPV (V11. 51)
Group 1CodeDescriptionZ11.51*Encounter for screening for human papillomavirus (HPV)
ICD-10 code Z12 for Encounter for screening for malignant neoplasms is a medical classification as listed by WHO under the range - Factors influencing health status and contact with health services .
The ICD-10-CM coding for this virus begins with vaccine administration. The code for vaccine administration or immunization is Z23 (Encounter for immunization).
K31. 89 - Other diseases of stomach and duodenum. ICD-10-CM.
Unspecified abnormal cytological findings in specimens from cervix uteri. R87. 619 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
810 for Cervical high risk human papillomavirus (HPV) DNA test positive is a medical classification as listed by WHO under the range - Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified .
Z12. 31 (Encounter for screening mammogram for malignant neoplasm of breast) is reported for screening mammograms while Z12. 39 (Encounter for other screening for malignant neoplasm of breast) has been established for reporting screening studies for breast cancer outside the scope of mammograms.
Z12. 11: Encounter for screening for malignant neoplasm of the colon.
Z12. 12 Encounter for screening for malignant neoplasm of rectum - ICD-10-CM Diagnosis Codes.
CPT code 90650 is an FDA-approved HPV vaccine for females only age 9-26. For recipients age 9-18, code 90650 is reimbursed through the VFC program. The three-dose schedule for either code for recipients over age 18 must begin and end before the recipient turns 27.
If the immunization is related to exposure (eg, the administration of a Tdap vaccine as a part of wound care), the ICD-10 code describing the exposure should be used as the primary diagnosis code for the vaccine, and Z23 should be used as the secondary code.
90471: Immunization administration for percutaneous, intra-dermal, subcutaneous or intramuscular injections, initial.
Gastroptosis is the abnormal downward displacement of the stomach. Although this condition is not life threatening is associated with constipation, discomfort, vomiting, dyspepsia, tenesmus, anorexia, nausea and belching.
811), Heyde's syndrome, Gastric antral vascular ectasia (GAVE) syndrome (ICD-10 K31. 819), Osler Weber Rendu Synrome (ICD-10 I78. 0) to list a few.
a patulous state or want of tone of the pylorus that allows the passage of food into the intestine before gastric digestion is completed.